EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 35 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 2.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $34,000 | -30.6% | 64,900 | 0.0% | 0.00% | – |
| Q2 2020 | $49,000 | -25.8% | 64,900 | 0.0% | 0.00% | – |
| Q1 2020 | $66,000 | -34.7% | 64,900 | 0.0% | 0.00% | – |
| Q4 2019 | $101,000 | -13.7% | 64,900 | 0.0% | 0.00% | – |
| Q3 2019 | $117,000 | +10.4% | 64,900 | 0.0% | 0.00% | – |
| Q2 2019 | $106,000 | -8.6% | 64,900 | 0.0% | 0.00% | – |
| Q1 2019 | $116,000 | -5.7% | 64,900 | 0.0% | 0.00% | – |
| Q4 2018 | $123,000 | -47.0% | 64,900 | 0.0% | 0.00% | – |
| Q3 2018 | $232,000 | +71.9% | 64,900 | 0.0% | 0.00% | – |
| Q2 2018 | $135,000 | – | 64,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,136,282 | $2,148,000 | 0.17% |
| EAM Investors, LLC | 237,409 | $449,000 | 0.12% |
| BARD ASSOCIATES INC | 89,559 | $169,000 | 0.10% |
| HighTower Advisors, LLC | 5,260,088 | $9,942,000 | 0.08% |
| Kore Private Wealth LLC | 75,866 | $143,000 | 0.04% |
| Regal Investment Advisors LLC | 69,950 | $132,000 | 0.03% |
| Paragon Capital Management Ltd | 24,750 | $47,000 | 0.02% |
| Alpine Global Management, LLC | 45,994 | $87,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 67,204 | $127,000 | 0.02% |
| BlueCrest Capital Management Ltd | 113,480 | $214,000 | 0.01% |